High Vista Strategies LLC Gritstone Bio, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $156,322 - $383,300	-88,318 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $102,499 - $310,040	-25,434 Reduced 22.36%	88,318 $364,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $869,859 - $1.36 Million	99,299 Added 687.05%	113,752 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $92,643 - $195,693	14,453 New	14,453 $156,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.